3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
22
Phase 4
3
Phase 2/3
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Breast
2
Other
1
Head & Neck
1
Genitourinary
1
Conditions
Obesity
1
Motor Activity
1
Breast Neoplasms
1
Interventions
tegaserod
1
semaglutide
1
penclomedine
1
aluminum hydroxide, magnesium hydroxide, drug combination
1
Thioctic Acid
1
Tablets
1
Radiation
1
Metformin
1
Megestrol Acetate
1
Low-Level Light Therapy
1
Lidocaine
1
Letrozole
1
LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)-
1
Exercise
1
Exenatide
1
Diphenhydramine
1
Buspirone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Exercise
×
Other
×
Clear all
NCT00393172
2019-11-01
WISER
University of Minnesota
Phase 2/3
Completed
400 enrolled